HCR
LIVE

Serial Number

98025098

Owner

Molecular Instruments, Inc.

Attorney

ROSALEEN H. CHOU

First Use Date

Feb 13, 2023

Filing Date

Jun 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

HCR Trademark

Serial Number: 98025098

HCR is a trademark filed by Molecular Instruments, Inc. on June 2, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Molecular Instruments, Inc.

5015 Eagle Rock Blvd #301
Los Angeles, CA 90041

Entity Type: 03

Trademark Details

Filing Date

June 2, 2023

Registration Date

Not Registered

First Use Anywhere

February 13, 2023

First Use in Commerce

February 13, 2023

Goods & Services

Medical services; Medical diagnostic testing services; Medical analysis services for diagnostic purposes and treatment decision and selection; Nucleic acid sequencing analysis services for medical diagnostic purposes and treatment decision and selection

Scientific research; Scientific and technological services, namely, scientific research, analysis, and testing in the medical, veterinary, and agricultural fields; Scientific and technological services, namely, scientific research, analysis, and testing in the field of reagents, assays, and nucleotides for scientific, medical, and agricultural use; Scientific research and development; Medical research; Research and development in the medical, veterinary, and agricultural fields; Research and development of technology in the field of nucleotides for scientific, medical, veterinary, and agricultural purposes; Clinical research in the field of genetics and skin disease prevention; Providing laboratory research services for research validation in the field of gene expression; DNA, RNA, and protein testing services for scientific research purposes; Research and development of new products for others, namely, diagnostic tests, clinical products, diagnostic agents and assays; Nucleic acid sequencing, screening, and analysis services for medical research purposes; Design, custom design, and development of kits containing reagents commonly known as buffers, probes, and amplifiers, reagents, assays, and nucleic acid sequences, being chemical preparations for scientific research, medical diagnostics, and veterinary diagnostics use; New product design services; Nucleic acid sequence design and analysis services for scientific research purposes; Medical research services; none of the foregoing related to the field of robotics; Medical research services in the field of genetics and skin disease prevention

Retail store services featuring reagents, assays, nucleotides, biological preparations for use in industry and science, chemical preparations for scientific purposes, chemical preparations for pharmaceutical or medical purposes, namely, for testing body fluids and tissues, diagnostic kits, reagent and assay kits; Online retail store services featuring reagents, assays, nucleotides, biological preparations for use in industry and science, chemical preparations for scientific purposes, chemical preparations for pharmaceutical or medical purposes, namely, for testing body fluids and tissues, diagnostic kits, and reagent and assay kits; Subscription-based order fulfillment services featuring reagents, assays, nucleotides, biological preparations for use in industry and science, chemical preparations for scientific purposes, chemical preparations for pharmaceutical or medical purposes, namely, for testing body fluids and tissues, diagnostic kits, reagent and assay kits

Filing History

NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
May 30, 2026 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
May 30, 2026 GECD
ACTION CONTINUING FINAL - COMPLETED
May 30, 2026 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2026 CRFA
ASSIGNED TO LIE
Apr 20, 2026 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 15, 2026 ERFR
EX PARTE APPEAL-INSTITUTED
Apr 15, 2026 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 15, 2026 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Apr 15, 2026 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 14, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 14, 2026 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 15, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 15, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 15, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2025 CRFA
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Aug 25, 2025 RGIA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 23, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 23, 2025 ABN2
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 4, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 4, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 4, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 4, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 24, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 12, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 12, 2024 GNSL
SUSPENSION LETTER WRITTEN
Nov 12, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 16, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 6, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 6, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 16, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 25, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 6, 2023 NWOS
NEW APPLICATION ENTERED
Jun 6, 2023 NWAP